34 results
POS AM
SYRE
Spyre Therapeutics Inc.
26 Mar 24
Prospectus update (post-effective amendment)
6:30pm
assessed will not be reassessed, (ii) templates that were developed and endorsed by the EU Clinical Trials Expert Group to provide compliance
POS AM
SYRE
Spyre Therapeutics Inc.
14 Mar 24
Prospectus update (post-effective amendment)
4:12pm
will not be reassessed, (ii) templates that were developed and endorsed by the EU Clinical Trials Expert Group to provide compliance with the CTR do not need
POS AM
v9nsvjjqx lzi8n0t7wa
5 Mar 24
Prospectus update (post-effective amendment)
5:15pm
424B3
vqj3e9xkvs7
6 Feb 24
Prospectus supplement
9:37pm
8-K
EX-3.1
u4xm2rydl
5 Feb 24
Entry into a Material Definitive Agreement
7:36am
8-K
EX-99.1
k94w04id3okw ej1hlo
8 Sep 23
Material Modifications to Rights of Security Holders
5:05pm
PRE 14A
ssi3 pqlc588v
7 Apr 23
Preliminary proxy
4:02pm
8-K
EX-3.1
53f16s
19 Dec 22
Amendments to Articles of Incorporation or Bylaws
4:06pm